These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1827746)

  • 21. Acute pancreatitis during oral 5-aminosalicylic acid therapy.
    Fiorentini MT; Fracchia M; Galatola G; Barlotta A; de la Pierre M
    Dig Dis Sci; 1990 Sep; 35(9):1180-2. PubMed ID: 2390934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
    Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute interstitial nephritis caused by 5-aminosalicylic acid?].
    Ruf-Ballauf W; Hofstädter F; Krentz K
    Internist (Berl); 1989 Apr; 30(4):262-4. PubMed ID: 2661466
    [No Abstract]   [Full Text] [Related]  

  • 24. Folliculitis and mesalamine.
    Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
    Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
    [No Abstract]   [Full Text] [Related]  

  • 25. Lung disease associated with orally administered mesalamine for ulcerative colitis.
    Reinoso MA; Schroeder KW; Pisani RJ
    Chest; 1992 May; 101(5):1469-71. PubMed ID: 1582327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease.
    Bondesen S; Rasmussen SN; Rask-Madsen J; Nielsen OH; Lauritsen K; Binder V; Hansen SH; Hvidberg EF
    Acta Med Scand; 1987; 221(3):227-42. PubMed ID: 3296672
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesalamine-induced lung toxicity.
    Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiac hypersensitivity to 5-aminosalicylic acid.
    Agnholt J; Sørensen HT; Rasmussen SN; Gøtzsche CO; Halkier P
    Lancet; 1989 May; 1(8647):1135. PubMed ID: 2566070
    [No Abstract]   [Full Text] [Related]  

  • 30. Balsalazide disodium.
    Am J Health Syst Pharm; 2002 Jan; 59(1):27. PubMed ID: 11813462
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of mesalamine and olsalazine in ulcerative colitis.
    Gait JE; Powell JH; Regalli G
    Am Fam Physician; 1993 Nov; 48(7):1234, 1236. PubMed ID: 8237737
    [No Abstract]   [Full Text] [Related]  

  • 32. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
    Sviri S; Gafanovich I; Kramer MR; Tsvang E; Ben-Chetrit E
    J Clin Gastroenterol; 1997 Jan; 24(1):34-6. PubMed ID: 9013348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypersensitivity reaction to balsalazide.
    Adhiyaman V; Vaishnavi A; Froese S
    BMJ; 2000 Mar; 320(7235):613. PubMed ID: 10698880
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis.
    Abdullah AM; Scott RB; Martin SR
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):441-4. PubMed ID: 8145103
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug points: Hypersensitivity reaction to balsalazide.
    Adhiyaman V; Vaishnavi A; Froese S
    BMJ; 2001 Sep; 323(7311):489. PubMed ID: 11532843
    [No Abstract]   [Full Text] [Related]  

  • 36. Five-aminosalicylic acid enemas in treatment of ulcerative colitis.
    Fedotin MS
    Mo Med; 1985 Jun; 82(6):301-3. PubMed ID: 4010664
    [No Abstract]   [Full Text] [Related]  

  • 37. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ; Mayer L; Abreu MT
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous hypersensitivity reaction to mesalazine.
    Aparicio J; Carnicer F; Girona E; Gmez A
    Am J Gastroenterol; 1996 Mar; 91(3):620-1. PubMed ID: 8633534
    [No Abstract]   [Full Text] [Related]  

  • 39. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.